ARIPIPRAZOLE ORAL

ARIPIPRAZOLE ORAL was reported 42262 times

These side effects are most commonly reported by patients taking ARIPIPRAZOLE ORAL:

# Side effect Count
0 DRUG INEFFECTIVE 4421
1 OFF LABEL USE 2952
2 DRUG INTERACTION 2286
3 PRODUCT USE IN UNAPPROVED INDICATION 2270
4 WEIGHT INCREASED 2162
5 ANXIETY 1796
6 CONDITION AGGRAVATED 1712
7 SUICIDE ATTEMPT 1582
8 FATIGUE 1545
9 SUICIDAL IDEATION 1449
10 TOXICITY TO VARIOUS AGENTS 1429
11 NAUSEA 1384
12 SOMNOLENCE 1363
13 SEDATION 1318
14 SCHIZOPHRENIA 1305
15 PSYCHOTIC DISORDER 1229
16 DEPRESSION 1220
17 INSOMNIA 1214
18 AKATHISIA 1194
19 TREMOR 1182
20 HEADACHE 1106
21 EXTRAPYRAMIDAL DISORDER 1097
22 DIZZINESS 1080
23 VOMITING 1012
24 DYSTONIA 955
25 NEUROLEPTIC MALIGNANT SYNDROME 952
26 TREATMENT NONCOMPLIANCE 948
27 OVERDOSE 940
28 DYSKINESIA 937
29 PAIN 910
30 AGITATION 894
31 DRUG ABUSE 869
32 ELECTROCARDIOGRAM QT PROLONGED 860
33 COMPLETED SUICIDE 854
34 HALLUCINATION, AUDITORY 846
35 DIARRHOEA 829
36 CONFUSIONAL STATE 828
37 DYSPNOEA 820
38 MALAISE 819
39 INTENTIONAL OVERDOSE 814
40 AGGRESSION 797
41 DEATH 756
42 GAMBLING DISORDER 744
43 FALL 733
44 CONSTIPATION 717
45 PARKINSONISM 717
46 TARDIVE DYSKINESIA 683
47 HYPOTENSION 680
48 SEXUAL DYSFUNCTION 676
49 FOETAL EXPOSURE DURING PREGNANCY 667
50 PYREXIA 656
51 NEUTROPENIA 648
52 ASTHENIA 635
53 DELUSION 635
54 TACHYCARDIA 631
55 SEIZURE 621
56 HYPERTENSION 617
57 MATERNAL EXPOSURE DURING PREGNANCY 613
58 PRODUCT USE ISSUE 610
59 RESTLESSNESS 600
60 IRRITABILITY 592
61 MENTAL DISORDER 573
62 GAIT DISTURBANCE 567
63 BLOOD GLUCOSE INCREASED 550
64 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 544
65 OBSESSIVE-COMPULSIVE DISORDER 542
66 ARTHRALGIA 530
67 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 530
68 DEPRESSED MOOD 523
69 HALLUCINATION 521
70 HOSPITALISATION 521
71 MEDICATION ERROR 518
72 SEROTONIN SYNDROME 518
73 ACUTE KIDNEY INJURY 513
74 FEELING ABNORMAL 511
75 HYPERHIDROSIS 507
76 TREATMENT FAILURE 504
77 PNEUMONIA 490
78 ABNORMAL BEHAVIOUR 486
79 MANIA 484
80 WEIGHT DECREASED 482
81 MENTAL IMPAIRMENT 477
82 RASH 476
83 PRODUCT DOSE OMISSION ISSUE 472
84 ECONOMIC PROBLEM 465
85 EMOTIONAL DISTRESS 462
86 INTENTIONAL SELF-INJURY 460
87 LEUKOPENIA 459
88 DIABETES MELLITUS 448
89 SALIVARY HYPERSECRETION 442
90 BLOOD CREATINE PHOSPHOKINASE INCREASED 440
91 HYPERPROLACTINAEMIA 436
92 MUSCULOSKELETAL STIFFNESS 435
93 LOSS OF CONSCIOUSNESS 434
94 METABOLIC DISORDER 426
95 BLOOD PROLACTIN ABNORMAL 423
96 DISTURBANCE IN ATTENTION 422
97 MEMORY IMPAIRMENT 418
98 SCHIZOAFFECTIVE DISORDER 418
99 CHEST PAIN 416
100 EXPOSURE DURING PREGNANCY 407
101 COGNITIVE DISORDER 402
102 DRUG LEVEL INCREASED 400
103 COMPULSIVE SHOPPING 397
104 INTENTIONAL PRODUCT MISUSE 396
105 RHABDOMYOLYSIS 394
106 SLEEP DISORDER 394
107 DECREASED APPETITE 388
108 PRURITUS 386
109 VISION BLURRED 386
110 WHITE BLOOD CELL COUNT DECREASED 381
111 NO ADVERSE EVENT 380
112 DELIRIUM 374
113 PARANOIA 371
114 COMA 363
115 PERSONALITY CHANGE 363
116 MYALGIA 362
117 MUSCLE SPASMS 361
118 ABDOMINAL PAIN 359
119 ANOSOGNOSIA 357
120 OBESITY 357
121 DYSPHAGIA 354
122 MYOCARDITIS 353
123 INJURY 346
124 DISTURBANCE IN SOCIAL BEHAVIOUR 341
125 PULMONARY EMBOLISM 336
126 MUSCLE RIGIDITY 334
127 URINARY TRACT INFECTION 333
128 DEPRESSED LEVEL OF CONSCIOUSNESS 332
129 BACK PAIN 330
130 THROMBOCYTOPENIA 330
131 OCULOGYRIC CRISIS 326
132 ALOPECIA 319
133 CARDIAC ARREST 319
134 PAIN IN EXTREMITY 319
135 SINUS TACHYCARDIA 319
136 DYSARTHRIA 318
137 ADVERSE DRUG REACTION 313
138 VERTIGO 313
139 CATATONIA 312
140 INCREASED APPETITE 312
141 PSYCHOTIC SYMPTOM 311
142 COUGH 310
143 ANHEDONIA 303
144 APATHY 301
145 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 299
146 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 297
147 SYNCOPE 295
148 DRUG DEPENDENCE 294
149 INCORRECT DOSE ADMINISTERED 293
150 CARDIO-RESPIRATORY ARREST 292
151 PSYCHOMOTOR HYPERACTIVITY 285
152 DEHYDRATION 284
153 MUSCULAR WEAKNESS 284
154 UNDERDOSE 282
155 HEART RATE INCREASED 278
156 DISORIENTATION 275
157 THERAPEUTIC RESPONSE DECREASED 275
158 C-REACTIVE PROTEIN INCREASED 274
159 SPEECH DISORDER 272
160 BALANCE DISORDER 270
161 URINARY INCONTINENCE 269
162 COVID-19 268
163 PERIPHERAL SWELLING 265
164 WHITE BLOOD CELL COUNT INCREASED 262
165 AMNESIA 258
166 DRUG INTOLERANCE 258
167 DRY MOUTH 258
168 LETHARGY 257
169 WITHDRAWAL SYNDROME 256
170 HALLUCINATION, VISUAL 253
171 ABDOMINAL PAIN UPPER 252
172 NEUTROPHIL COUNT INCREASED 249
173 EUPHORIC MOOD 248
174 NEUTROPHIL COUNT DECREASED 248
175 EATING DISORDER 246
176 THINKING ABNORMAL 246
177 BLOOD PRESSURE INCREASED 244
178 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 244
179 ANGER 242
180 VISUAL IMPAIRMENT 241
181 THERAPY CESSATION 240
182 ANAEMIA 237
183 PLATELET COUNT DECREASED 234
184 BRADYCARDIA 233
185 THERAPY NON-RESPONDER 232
186 PREMATURE BABY 231
187 RESPIRATORY DEPRESSION 230
188 URINARY RETENTION 230
189 TYPE 2 DIABETES MELLITUS 229
190 OEDEMA PERIPHERAL 228
191 CHRONIC KIDNEY DISEASE 221
192 HYPERSEXUALITY 221
193 ABORTION SPONTANEOUS 219
194 HYPONATRAEMIA 218
195 RENAL FAILURE 217
196 PALPITATIONS 216
197 PARAESTHESIA 212
198 DISABILITY 209
199 SEDATION COMPLICATION 208
200 ASTHMA 207
201 DISEASE RECURRENCE 207
202 IMPULSIVE BEHAVIOUR 207
203 ADVERSE EVENT 206
204 ALTERED STATE OF CONSCIOUSNESS 205
205 ALANINE AMINOTRANSFERASE INCREASED 204
206 HYPOAESTHESIA 203
207 SOCIAL AVOIDANT BEHAVIOUR 202
208 INJECTION SITE PAIN 200
209 SEPSIS 200
210 DISINHIBITION 199
211 DYSPEPSIA 199
212 ILLNESS 198
213 BIPOLAR DISORDER 196
214 PRESCRIBED OVERDOSE 196
215 DRUG HYPERSENSITIVITY 195
216 INSURANCE ISSUE 195
217 PERSECUTORY DELUSION 195
218 MIGRAINE 193
219 ABDOMINAL DISCOMFORT 190
220 STRESS 189
221 RESTLESS LEGS SYNDROME 188
222 MOVEMENT DISORDER 187
223 PNEUMONIA ASPIRATION 187
224 OXYGEN SATURATION DECREASED 186
225 AFFECTIVE DISORDER 185
226 GESTATIONAL DIABETES 185
227 BLOOD CHOLESTEROL INCREASED 184
228 ANTIPSYCHOTIC DRUG LEVEL INCREASED 183
229 DRUG RESISTANCE 183
230 HAEMOGLOBIN DECREASED 183
231 POISONING DELIBERATE 183
232 HYPERGLYCAEMIA 182
233 HYPERSENSITIVITY 182
234 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 180
235 ERYTHEMA 180
236 INFECTION 180
237 NEUROPATHY PERIPHERAL 180
238 RENAL IMPAIRMENT 180
239 MOOD SWINGS 179
240 HYPERSOMNIA 178
241 PRODUCT PRESCRIBING ERROR 178
242 NASOPHARYNGITIS 174
243 CRYING 173
244 PRESCRIBED UNDERDOSE 173
245 GENERAL PHYSICAL HEALTH DETERIORATION 170
246 SOPOR 170
247 LEUKOCYTOSIS 169
248 RESPIRATORY FAILURE 169
249 ABDOMINAL DISTENSION 166
250 BLOOD PROLACTIN INCREASED 166
251 HYPOTHERMIA 166
252 OROPHARYNGEAL PAIN 165
253 ORTHOSTATIC HYPOTENSION 165
254 MYOCARDIAL INFARCTION 164
255 COMPULSIVE SEXUAL BEHAVIOUR 163
256 THERAPY PARTIAL RESPONDER 161
257 HYPOMANIA 160
258 PRODUCT SUBSTITUTION ISSUE 158
259 IMPULSE-CONTROL DISORDER 157
260 MUSCLE TWITCHING 157
261 DYSLIPIDAEMIA 155
262 INFLUENZA 154
263 LOWER RESPIRATORY TRACT INFECTION 154
264 CHEST DISCOMFORT 152
265 MYOCLONUS 152
266 URTICARIA 152
267 ARRHYTHMIA 151
268 DRUG WITHDRAWAL SYNDROME 151
269 ERECTILE DYSFUNCTION 151
270 INTENTIONAL PRODUCT USE ISSUE 151
271 MOOD ALTERED 150
272 DEEP VEIN THROMBOSIS 147
273 NERVOUSNESS 147
274 DIABETIC KETOACIDOSIS 145
275 GALACTORRHOEA 145
276 LYMPHOCYTE COUNT DECREASED 144
277 NIGHTMARE 144
278 BANKRUPTCY 143
279 LOSS OF EMPLOYMENT 143
280 RESPIRATORY ARREST 141
281 CHILLS 140
282 HEPATIC FUNCTION ABNORMAL 140
283 EPILEPSY 139
284 HYPOTHYROIDISM 139
285 BLOOD TRIGLYCERIDES INCREASED 138
286 BLOOD CREATININE INCREASED 137
287 MENTAL STATUS CHANGES 137
288 PANIC ATTACK 137
289 SLEEP APNOEA SYNDROME 137
290 CELLULITIS 136
291 GASTROINTESTINAL DISORDER 136
292 CONTUSION 135
293 PRODUCT AVAILABILITY ISSUE 135
294 PSYCHIATRIC SYMPTOM 135
295 ASPARTATE AMINOTRANSFERASE INCREASED 134
296 JOINT SWELLING 134
297 ENCEPHALOPATHY 133
298 UNRESPONSIVE TO STIMULI 133
299 BRONCHITIS 131
300 THERAPY INTERRUPTED 131
301 DISEASE PROGRESSION 130
302 AFFECT LABILITY 129
303 CARDIAC DISORDER 129
304 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 128
305 ATRIAL FIBRILLATION 127
306 THERAPEUTIC PRODUCT EFFECT VARIABLE 127
307 BLOOD PRESSURE DECREASED 126
308 METABOLIC SYNDROME 126
309 GASTROOESOPHAGEAL REFLUX DISEASE 125
310 FEAR 123
311 GYNAECOMASTIA 123
312 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 123
313 PANCREATITIS 123
314 PSYCHIATRIC DECOMPENSATION 123
315 SUBSTANCE ABUSE 123
316 CEREBROVASCULAR ACCIDENT 122
317 PULMONARY OEDEMA 122
318 TROPONIN INCREASED 122
319 AMENORRHOEA 121
320 COORDINATION ABNORMAL 121
321 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 120
322 HYPOKINESIA 120
323 GENERALISED TONIC-CLONIC SEIZURE 119
324 HYPOGLYCAEMIA 119
325 DROOLING 118
326 DYSURIA 118
327 EMOTIONAL DISORDER 118
328 POOR QUALITY SLEEP 118
329 BEHAVIOUR DISORDER 117
330 METABOLIC ACIDOSIS 117
331 ATAXIA 116
332 DEMENTIA 116
333 HYPOKALAEMIA 116
334 MOBILITY DECREASED 116
335 BRADYKINESIA 115
336 RED BLOOD CELL COUNT DECREASED 115
337 BRADYPHRENIA 114
338 DISCOMFORT 112
339 DRUG DOSE OMISSION 112
340 MYDRIASIS 112
341 PSORIASIS 112
342 APHASIA 111
343 RHINORRHOEA 110
344 DRY EYE 109
345 PANCREATITIS ACUTE 109
346 TRISMUS 109
347 DYSPHONIA 108
348 PARKINSON^S DISEASE 108
349 DRY SKIN 107
350 NECK PAIN 107
351 BRUXISM 106
352 INFLUENZA LIKE ILLNESS 106
353 PANCYTOPENIA 106
354 TIC 106
355 DEPRESSIVE SYMPTOM 105
356 LIVER FUNCTION TEST ABNORMAL 105
357 EOSINOPHILIA 104
358 HYPERPHAGIA 104
359 NASAL CONGESTION 104
360 LEUKAEMIA 103
361 INABILITY TO AFFORD MEDICATION 102
362 PREMATURE DELIVERY 102
363 PRIAPISM 102
364 PSYCHOMOTOR RETARDATION 102
365 AUTISM SPECTRUM DISORDER 100
366 COGWHEEL RIGIDITY 100
367 EOSINOPHIL COUNT DECREASED 100
368 EPISTAXIS 100
369 PARADOXICAL DRUG REACTION 100
370 VENTRICULAR SEPTAL DEFECT 100
371 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 99
372 FEELING HOT 99
373 CARDIOMYOPATHY 98
374 HALLUCINATIONS, MIXED 98
375 HEAD INJURY 98
376 INFARCTION 98
377 MAJOR DEPRESSION 97
378 BLOOD ALKALINE PHOSPHATASE INCREASED 96
379 GAMBLING 96
380 HEPATIC ENZYME INCREASED 96
381 REFUSAL OF TREATMENT BY PATIENT 96
382 DYSSTASIA 94
383 HYPERAMMONAEMIA 94
384 LIBIDO DECREASED 94
385 POLLAKIURIA 94
386 RHEUMATOID ARTHRITIS 94
387 AGRANULOCYTOSIS 93
388 BRAIN FOG 93
389 INTESTINAL OBSTRUCTION 92
390 POSTURE ABNORMAL 92
391 EYE PAIN 91
392 PRODUCT DOSE OMISSION 91
393 TORTICOLLIS 91
394 MONOCYTE COUNT INCREASED 90
395 ACCIDENTAL OVERDOSE 89
396 BODY TEMPERATURE INCREASED 89
397 HAEMORRHAGE 89
398 HYPERTHERMIA 89
399 LOSS OF LIBIDO 89
400 SUSPECTED SUICIDE 89
401 THROMBOSIS 89
402 CAESAREAN SECTION 88
403 DRUG-INDUCED LIVER INJURY 88
404 GLYCOSYLATED HAEMOGLOBIN INCREASED 88
405 HOMICIDAL IDEATION 88
406 LIVE BIRTH 88
407 SUBSTANCE USE DISORDER 88
408 SWELLING 88
409 ABNORMAL WEIGHT GAIN 87
410 CARDIAC FAILURE 87
411 HICCUPS 87
412 WHEEZING 87
413 ACUTE PSYCHOSIS 86
414 BURNING SENSATION 86
415 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 86
416 ROAD TRAFFIC ACCIDENT 86
417 SWELLING FACE 86
418 HOMELESS 85
419 SINUSITIS 85
420 DELUSION OF GRANDEUR 84
421 LOGORRHOEA 84
422 PERICARDITIS 84
423 HYPOPHAGIA 83
424 LEFT VENTRICULAR DYSFUNCTION 83
425 CONTRAINDICATED PRODUCT ADMINISTERED 82
426 HAEMATOCRIT DECREASED 82
427 HEART RATE DECREASED 82
428 HEPATIC STEATOSIS 82
429 HYPERREFLEXIA 82
430 ARTHRITIS 81
431 HYPERTONIA 81
432 ANGIOEDEMA 80
433 LIBIDO INCREASED 80
434 BLEPHAROSPASM 79
435 HYPERNATRAEMIA 79
436 HYPOXIA 79
437 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 79
438 VICTIM OF CRIME 79
439 BINGE EATING 78
440 DIVORCED 78
441 MIOSIS 78
442 SELF-INJURIOUS IDEATION 78
443 SKIN EXFOLIATION 78
444 SOCIAL PROBLEM 78
445 SWOLLEN TONGUE 78
446 TENSION 78
447 POLYURIA 77
448 BLOOD GLUCOSE DECREASED 76
449 HEPATIC CYTOLYSIS 76
450 TORSADE DE POINTES 76
451 BLOOD PRESSURE FLUCTUATION 75
452 EYE MOVEMENT DISORDER 75
453 PRODUCT PRESCRIBING ISSUE 75
454 REBOUND EFFECT 75
455 UNEVALUABLE EVENT 75
456 BRAIN INJURY 74
457 MUCOSAL INFLAMMATION 74
458 SELF-DESTRUCTIVE BEHAVIOUR 74
459 SURGERY 74
460 DEPENDENCE 73
461 OEDEMA 73
462 POISONING 73
463 PRODUCT DOSE OMISSION IN ERROR 73
464 ANAPHYLACTIC REACTION 72
465 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 72
466 COMA SCALE ABNORMAL 72
467 FLUSHING 72
468 NERVOUS SYSTEM DISORDER 72
469 NEUTROPHILIA 72
470 STAPHYLOCOCCAL INFECTION 72
471 TINNITUS 72
472 TRANSAMINASES INCREASED 72
473 HYPERLIPIDAEMIA 71
474 INFLAMMATION 71
475 COMPULSIVE HOARDING 70
476 DRUG EFFECT INCOMPLETE 70
477 FEEDING DISORDER 70
478 GAMMA-GLUTAMYLTRANSFERASE INCREASED 70
479 HYPERKALAEMIA 70
480 LIVER INJURY 70
481 ORTHOSTATIC HYPERTENSION 70
482 AUTONOMIC NERVOUS SYSTEM IMBALANCE 69
483 CONVULSION 69
484 ELECTROCARDIOGRAM ABNORMAL 69
485 OSTEOPOROSIS 69
486 PALLOR 69
487 POST-TRAUMATIC STRESS DISORDER 69
488 POTENTIATING DRUG INTERACTION 69
489 PSORIATIC ARTHROPATHY 69
490 RESPIRATORY DISTRESS 69
491 STEVENS-JOHNSON SYNDROME 69
492 TACHYPNOEA 69
493 THEFT 69
494 THERAPEUTIC PRODUCT EFFECT DECREASED 69
495 THROAT IRRITATION 69
496 BIPOLAR I DISORDER 68
497 EJECTION FRACTION DECREASED 68
498 LACTIC ACIDOSIS 68
499 PREGNANCY 68
500 PRODUCT ADMINISTRATION ERROR 68
501 SARS-COV-2 TEST POSITIVE 68
502 SINUS BRADYCARDIA 68
503 ACUTE RESPIRATORY DISTRESS SYNDROME 67
504 DRUG USE DISORDER 67
505 IMPAIRED GASTRIC EMPTYING 67
506 NEUROPSYCHIATRIC SYMPTOMS 67
507 STUPOR 67
508 HYPERCHOLESTEROLAEMIA 66
509 INCONTINENCE 66
510 LOW BIRTH WEIGHT BABY 66
511 SYMPTOM RECURRENCE 66
512 ANGINA PECTORIS 65
513 BLOOD UREA INCREASED 65
514 JOINT STIFFNESS 65
515 RENAL DISORDER 65
516 STATUS EPILEPTICUS 65
517 GASTROINTESTINAL HAEMORRHAGE 64
518 MATERNAL EXPOSURE DURING BREAST FEEDING 64
519 MITRAL VALVE INCOMPETENCE 64
520 ATRIAL SEPTAL DEFECT 63
521 BONE PAIN 63
522 CARDIOGENIC SHOCK 63
523 DRUG EFFECT LESS THAN EXPECTED 63
524 DRUG LEVEL ABOVE THERAPEUTIC 63
525 SOMNAMBULISM 63
526 STEREOTYPY 63
527 ACUTE RESPIRATORY FAILURE 62
528 ANTIPSYCHOTIC DRUG LEVEL DECREASED 62
529 DERMATITIS ATOPIC 62
530 ELECTROENCEPHALOGRAM ABNORMAL 62
531 FIBROMYALGIA 62
532 GAZE PALSY 62
533 IMPAIRED QUALITY OF LIFE 62
534 PLEURAL EFFUSION 62
535 PULMONARY CONGESTION 62
536 ABNORMAL DREAMS 61
537 CHOLELITHIASIS 61
538 CIRCULATORY COLLAPSE 61
539 ECZEMA 61
540 FLATULENCE 61
541 ILEUS 61
542 INITIAL INSOMNIA 61
543 PHOTOSENSITIVITY REACTION 61
544 PLATELET COUNT INCREASED 61
545 DIPLOPIA 60
546 HOT FLUSH 60
547 HYPOTONIA 60
548 SCREAMING 60
549 THERAPEUTIC RESPONSE UNEXPECTED 60
550 MIDDLE INSOMNIA 59
551 MULTIPLE ORGAN DYSFUNCTION SYNDROME 59
552 OROMANDIBULAR DYSTONIA 59
553 PERICARDIAL EFFUSION 59
554 THIRST 59
555 LIMB DISCOMFORT 58
556 MULTIPLE SCLEROSIS 58
557 PERSONALITY DISORDER 58
558 POLYDIPSIA 58
559 PRESYNCOPE 58
560 THERAPY CHANGE 58
561 BLISTER 57
562 BLOOD PHOSPHORUS DECREASED 57
563 PERITONITIS 57
564 RHINALGIA 57
565 SUPRAVENTRICULAR TACHYCARDIA 57
566 VENTRICULAR TACHYCARDIA 57
567 CHOKING 56
568 DISSOCIATION 56
569 INFUSION RELATED REACTION 56
570 JUVENILE IDIOPATHIC ARTHRITIS 56
571 LYMPHOCYTE COUNT ABNORMAL 56
572 MENSTRUATION IRREGULAR 56
573 SKIN DISCOLOURATION 56
574 SUICIDAL BEHAVIOUR 56
575 TONGUE BITING 56
576 BLOOD SODIUM DECREASED 55
577 EPIDURAL LIPOMATOSIS 55
578 FOOD CRAVING 55
579 HYPERTRIGLYCERIDAEMIA 55
580 MULTIPLE SCLEROSIS RELAPSE 55
581 MUSCLE TIGHTNESS 55
582 SUDDEN DEATH 55
583 ATELECTASIS 54
584 EMOTIONAL POVERTY 54
585 ENURESIS 54
586 FLAT AFFECT 54
587 HAEMATOCHEZIA 54
588 INTERVERTEBRAL DISC PROTRUSION 54
589 ISCHAEMIC STROKE 54
590 PRODUCT ADMINISTRATION INTERRUPTED 54
591 PRODUCTIVE COUGH 54
592 RED BLOOD CELL SEDIMENTATION RATE INCREASED 54
593 TOXIC EPIDERMAL NECROLYSIS 54
594 VISUAL ACUITY REDUCED 54
595 VITAMIN D DEFICIENCY 54
596 ACNE 53
597 ANAL INCONTINENCE 53
598 CARDIOMEGALY 53
599 CONCUSSION 53
600 DYSPHORIA 53
601 END STAGE RENAL DISEASE 53
602 MEGACOLON 53
603 PHOTOPHOBIA 53
604 SHOCK 53
605 TENDERNESS 53
606 TRICUSPID VALVE INCOMPETENCE 53
607 BLOOD TEST ABNORMAL 52
608 BUNDLE BRANCH BLOCK RIGHT 52
609 DECREASED INTEREST 52
610 EYE IRRITATION 52
611 GRANULOCYTOPENIA 52
612 HAEMODYNAMIC INSTABILITY 52
613 HOSTILITY 52
614 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 52
615 LYMPHADENOPATHY 52
616 OBSESSIVE THOUGHTS 52
617 OCULAR HYPERAEMIA 52
618 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 52
619 ASPHYXIA 51
620 FEBRILE NEUTROPENIA 51
621 FOETAL DISORDER 51
622 HEPATOCELLULAR INJURY 51
623 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 51
624 MUSCLE CONTRACTIONS INVOLUNTARY 51
625 POOR PERSONAL HYGIENE 51
626 UPPER RESPIRATORY TRACT INFECTION 51
627 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 50
628 ARTERIOSCLEROSIS CORONARY ARTERY 50
629 HAEMATEMESIS 50
630 ILL-DEFINED DISORDER 50
631 INAPPROPRIATE AFFECT 50
632 OSTEOARTHRITIS 50
633 RASH PRURITIC 50
634 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 50
635 SHOPLIFTING 50
636 THERAPEUTIC RESPONSE SHORTENED 50
637 ADRENAL INSUFFICIENCY 49
638 ASPIRATION 49
639 BLINDNESS 49
640 DRUG LEVEL DECREASED 49
641 EAR PAIN 49
642 IMPAIRED WORK ABILITY 49
643 NEOPLASM PROGRESSION 49
644 NEPHROGENIC DIABETES INSIPIDUS 49
645 OVERWEIGHT 49
646 SEPTIC SHOCK 49
647 SLUGGISHNESS 49
648 STARING 49
649 TEARFULNESS 49
650 VAGINAL HAEMORRHAGE 49
651 BLOOD POTASSIUM DECREASED 48
652 CHOREOATHETOSIS 48
653 CROHN^S DISEASE 48
654 MUTISM 48
655 NICOTINE DEPENDENCE 48
656 PLEUROTHOTONUS 48
657 TACHYPHRENIA 48
658 TOXIC ENCEPHALOPATHY 48
659 VICTIM OF CHILD ABUSE 48
660 AGITATION NEONATAL 47
661 BLUNTED AFFECT 47
662 EYE DISORDER 47
663 MEAN CELL HAEMOGLOBIN DECREASED 47
664 NEPHROLITHIASIS 47
665 PARALYSIS 47
666 RED CELL DISTRIBUTION WIDTH INCREASED 47
667 TEMPERATURE INTOLERANCE 47
668 TRANSIENT ISCHAEMIC ATTACK 47
669 BLOOD BILIRUBIN INCREASED 46
670 CARDIAC FAILURE CONGESTIVE 46
671 CATARACT 46
672 CLONUS 46
673 MULTIPLE FRACTURES 46
674 SINUS RHYTHM 46
675 BLOOD ALBUMIN DECREASED 45
676 CHILD ABUSE 45
677 CONSCIOUSNESS FLUCTUATING 45
678 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 45
679 HUNGER 45
680 IRRITABLE BOWEL SYNDROME 45
681 JAUNDICE 45
682 NYSTAGMUS 45
683 PSYCHOMOTOR SKILLS IMPAIRED 45
684 RESPIRATORY TRACT INFECTION 45
685 SKIN DISORDER 45
686 ALCOHOL ABUSE 44
687 DERMATILLOMANIA 44
688 DRUG LEVEL BELOW THERAPEUTIC 44
689 DYSGEUSIA 44
690 HEPATIC FAILURE 44
691 HYPERKINESIA 44
692 INTERSTITIAL LUNG DISEASE 44
693 PERSONAL RELATIONSHIP ISSUE 44
694 PREMATURE LABOUR 44
695 RENAL INJURY 44
696 RENAL TUBULAR NECROSIS 44
697 SELECTIVE EATING DISORDER 44
698 STRESS CARDIOMYOPATHY 44
699 TUBULOINTERSTITIAL NEPHRITIS 44
700 CLOSTRIDIUM DIFFICILE INFECTION 43
701 DISSEMINATED INTRAVASCULAR COAGULATION 43
702 HYPERTENSIVE CRISIS 43
703 LIVER DISORDER 43
704 OPPOSITIONAL DEFIANT DISORDER 43
705 BRAIN OEDEMA 42
706 FEELING JITTERY 42
707 FULL BLOOD COUNT ABNORMAL 42
708 GAIT INABILITY 42
709 HEART RATE IRREGULAR 42
710 MENORRHAGIA 42
711 NEOPLASM MALIGNANT 42
712 PAIN IN JAW 42
713 POOR FEEDING INFANT 42
714 PRODUCT QUALITY ISSUE 42
715 QUALITY OF LIFE DECREASED 42
716 RASH ERYTHEMATOUS 42
717 SKIN IRRITATION 42
718 SOCIAL ANXIETY DISORDER 42
719 ULCER 42
720 ACUTE HEPATIC FAILURE 41
721 APNOEA 41
722 BEDRIDDEN 41
723 COLITIS ISCHAEMIC 41
724 GASTROENTERITIS 41
725 GLOMERULAR FILTRATION RATE DECREASED 41
726 HEPATOMEGALY 41
727 HYPOSPADIAS 41
728 PHOTOPSIA 41
729 SUDDEN CARDIAC DEATH 41
730 SUPPRESSED LACTATION 41
731 WRONG PATIENT RECEIVED PRODUCT 41
732 ACCIDENT 40
733 ACCIDENTAL EXPOSURE TO PRODUCT 40
734 BLOOD PRESSURE SYSTOLIC DECREASED 40
735 COMPULSIONS 40
736 DECREASED ACTIVITY 40
737 HEPATITIS 40
738 INSULIN RESISTANCE 40
739 INTESTINAL PERFORATION 40
740 JOINT DISLOCATION 40
741 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 40
742 LIVER FUNCTION TEST INCREASED 40
743 LOW DENSITY LIPOPROTEIN INCREASED 40
744 NEUROTOXICITY 40
745 SEASONAL ALLERGY 40
746 SOLILOQUY 40
747 VITAMIN B12 DEFICIENCY 40
748 WHITE BLOOD CELLS URINE POSITIVE 40
749 ABORTION INDUCED 39
750 APRAXIA 39
751 FOETAL GROWTH RESTRICTION 39
752 HERPES ZOSTER 39
753 INJECTION SITE REACTION 39
754 INTENTIONAL DOSE OMISSION 39
755 LIP SWELLING 39
756 MYOCARDIAL ISCHAEMIA 39
757 PULMONARY HYPERTENSION 39
758 TRICHOTILLOMANIA 39
759 TROPONIN T INCREASED 39
760 ACUTE MYOPIA 38
761 ANKLE FRACTURE 38
762 BLOOD PRESSURE ABNORMAL 38
763 COAGULOPATHY 38
764 CYANOSIS 38
765 DELUSIONAL DISORDER, UNSPECIFIED TYPE 38
766 DRUG WITHDRAWAL SYNDROME NEONATAL 38
767 DRUG-GENETIC INTERACTION 38
768 DYSPHEMIA 38
769 FACIAL PARALYSIS 38
770 FEELING COLD 38
771 HEAD DISCOMFORT 38
772 LYMPHOPENIA 38
773 SLOW SPEECH 38
774 SMALL FOR DATES BABY 38
775 STOMATITIS 38
776 BLOOD THYROID STIMULATING HORMONE INCREASED 37
777 BLOOD URIC ACID INCREASED 37
778 BUNDLE BRANCH BLOCK LEFT 37
779 DISORGANISED SPEECH 37
780 DRUG EXPOSURE DURING PREGNANCY 37
781 GASTRIC DISORDER 37
782 GASTRITIS 37
783 GLUCOSE TOLERANCE IMPAIRED 37
784 HAEMOLYTIC ANAEMIA 37
785 HYPERVENTILATION 37
786 INJECTION SITE ERYTHEMA 37
787 PRODUCT DISPENSING ERROR 37
788 SPINAL DISORDER 37
789 SUBSTANCE USE 37
790 SYNOVITIS 37
791 TOOTH LOSS 37
792 AGEUSIA 36
793 CYSTITIS 36
794 ELECTROLYTE IMBALANCE 36
795 HIGH DENSITY LIPOPROTEIN DECREASED 36
796 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 36
797 MUSCLE DISORDER 36
798 SEXUALLY INAPPROPRIATE BEHAVIOUR 36
799 BLOOD PRESSURE DIASTOLIC DECREASED 35
800 CARDIAC FAILURE ACUTE 35
801 CHOLECYSTITIS ACUTE 35
802 CHOLESTASIS 35
803 DRUG EFFECT DECREASED 35
804 FAECALOMA 35
805 FEAR OF DEATH 35
806 FLUID RETENTION 35
807 HAEMATOMA 35
808 HEAD TITUBATION 35
809 HYPERTONIC BLADDER 35
810 INJECTION SITE SWELLING 35
811 LACRIMATION INCREASED 35
812 LACTATION INSUFFICIENCY 35
813 NIGHT SWEATS 35
814 NORMAL NEWBORN 35
815 RASH MACULO-PAPULAR 35
816 RENAL FAILURE ACUTE 35
817 SELF-MEDICATION 35
818 SUSPICIOUSNESS 35
819 VIRAL INFECTION 35
820 AMYLASE INCREASED 34
821 BLOOD PRESSURE SYSTOLIC INCREASED 34
822 CARDIOTOXICITY 34
823 CEREBRAL INFARCTION 34
824 CONJUNCTIVITIS 34
825 DECREASED EYE CONTACT 34
826 DRUG CLEARANCE DECREASED 34
827 EOSINOPHILIC MYOCARDITIS 34
828 NEGATIVE SYMPTOMS IN SCHIZOPHRENIA 34
829 RASH GENERALISED 34
830 RASH MACULAR 34
831 SINUS CONGESTION 34
832 THROAT TIGHTNESS 34
833 TOOTHACHE 34
834 ACIDOSIS 33
835 DIZZINESS POSTURAL 33
836 DYSTONIC TREMOR 33
837 EOSINOPHIL COUNT INCREASED 33
838 FACE OEDEMA 33
839 GENERALISED OEDEMA 33
840 HYPOACUSIS 33
841 LIGAMENT SPRAIN 33
842 MEAN CELL VOLUME DECREASED 33
843 MICTURITION URGENCY 33
844 MYOPIA 33
845 PHARYNGITIS 33
846 PULMONARY VALVE INCOMPETENCE 33
847 SPLENOMEGALY 33
848 VITAMIN B12 INCREASED 33
849 WOUND 33
850 AKINESIA 32
851 CEREBRAL DISORDER 32
852 CLEFT PALATE 32
853 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 32
854 EXPOSURE VIA BREAST MILK 32
855 EYE PRURITUS 32
856 MALIGNANT CATATONIA 32
857 NARCOLEPSY 32
858 NEGATIVE THOUGHTS 32
859 PARKINSONIAN GAIT 32
860 PETIT MAL EPILEPSY 32
861 SCIATICA 32
862 SCRATCH 32
863 SEXUALLY TRANSMITTED DISEASE 32
864 SNEEZING 32
865 SPASMODIC DYSPHONIA 32
866 URINE ODOUR ABNORMAL 32
867 APPETITE DISORDER 31
868 BODY TEMPERATURE ABNORMAL 31
869 BONE DENSITY DECREASED 31
870 COMMUNICATION DISORDER 31
871 EAR INFECTION 31
872 ENCEPHALITIS 31
873 GLOMERULAR FILTRATION RATE INCREASED 31
874 ILLUSION 31
875 INTERNATIONAL NORMALISED RATIO INCREASED 31
876 LANGUAGE DISORDER 31
877 LIMB INJURY 31
878 NEURODEGENERATIVE DISORDER 31
879 NEUTROPENIA NEONATAL 31
880 TONGUE MOVEMENT DISTURBANCE 31
881 ABSCESS 30
882 ANORGASMIA 30
883 ANTICHOLINERGIC SYNDROME 30
884 BLOOD LACTATE DEHYDROGENASE INCREASED 30
885 CENTRAL NERVOUS SYSTEM LESION 30
886 CONGESTIVE CARDIOMYOPATHY 30
887 DEVICE ISSUE 30
888 INJECTION SITE MASS 30
889 LEFT VENTRICULAR HYPERTROPHY 30
890 LONG QT SYNDROME 30
891 MATERNAL DRUGS AFFECTING FOETUS 30
892 PARTIAL SEIZURES 30
893 PHYSICAL ASSAULT 30
894 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 30
895 RESPIRATORY DISORDER 30
896 RESTING TREMOR 30
897 RIB FRACTURE 30
898 SENSATION OF FOREIGN BODY 30
899 THROAT CLEARING 30
900 TROPONIN I INCREASED 30
901 ACUTE MYOCARDIAL INFARCTION 29
902 BICYTOPENIA 29
903 DEMYELINATION 29
904 DENTAL CARIES 29
905 DISTRIBUTIVE SHOCK 29
906 DISTURBANCE IN SEXUAL AROUSAL 29
907 ERYTHEMA MULTIFORME 29
908 FOOT FRACTURE 29
909 GASTROENTERITIS VIRAL 29
910 GRANULOCYTE COUNT INCREASED 29
911 HAEMOGLOBIN INCREASED 29
912 HERNIA 29
913 HYPOCALCAEMIA 29
914 INHIBITORY DRUG INTERACTION 29
915 IRON DEFICIENCY ANAEMIA 29
916 JUDGEMENT IMPAIRED 29
917 LIPASE INCREASED 29
918 NEGATIVISM 29
919 PERIPHERAL COLDNESS 29
920 PRE-ECLAMPSIA 29
921 RAYNAUD^S PHENOMENON 29
922 RETCHING 29
923 SKIN LESION 29
924 TASTE DISORDER 29
925 TONSILLITIS 29
926 VITAMIN B12 DECREASED 29
927 ABULIA 28
928 ATTENTION DEFICIT HYPERACTIVITY DISORDER 28
929 BLOOD GLUCOSE ABNORMAL 28
930 BREAST ENLARGEMENT 28
931 COLD SWEAT 28
932 DACTYLITIS 28
933 DRUG ERUPTION 28
934 DRUG SCREEN POSITIVE 28
935 DYSPNOEA EXERTIONAL 28
936 ELECTRIC SHOCK SENSATION 28
937 EXTRA DOSE ADMINISTERED 28
938 HAEMOPTYSIS 28
939 HEAVY MENSTRUAL BLEEDING 28
940 INTERVERTEBRAL DISCITIS 28
941 INTRACRANIAL PRESSURE INCREASED 28
942 JOINT NOISE 28
943 KIDNEY INFECTION 28
944 MENSTRUAL DISORDER 28
945 MULTIPLE DRUG THERAPY 28
946 NEGLECT OF PERSONAL APPEARANCE 28
947 PERIPHERAL ARTERY THROMBOSIS 28
948 POST CHOLECYSTECTOMY SYNDROME 28
949 RECTAL HAEMORRHAGE 28
950 RECTAL PROLAPSE 28
951 RESPIRATORY RATE INCREASED 28
952 SENSORY DISTURBANCE 28
953 SUBSTANCE DEPENDENCE 28
954 TONGUE DISORDER 28
955 ATRIOVENTRICULAR BLOCK FIRST DEGREE 27
956 BLOOD IMMUNOGLOBULIN A INCREASED 27
957 BODY MASS INDEX INCREASED 27
958 CANDIDA INFECTION 27
959 CHOLESTASIS OF PREGNANCY 27
960 CHOREA 27
961 COLITIS 27
962 COLITIS ULCERATIVE 27
963 DEPERSONALISATION/DEREALISATION DISORDER 27
964 ELECTRIC SHOCK 27
965 EXPOSURE DURING BREAST FEEDING 27
966 FEMUR FRACTURE 27
967 FREQUENT BOWEL MOVEMENTS 27
968 FUNGAL INFECTION 27
969 HEAT STROKE 27
970 HYPOPROLACTINAEMIA 27
971 INTELLECTUAL DISABILITY 27
972 INTRUSIVE THOUGHTS 27
973 LARYNGITIS 27
974 MUSCULOSKELETAL PAIN 27
975 MYCOBACTERIUM FORTUITUM INFECTION 27
976 ORAL CANDIDIASIS 27
977 OROPHARYNGEAL DISCOMFORT 27
978 PHARYNGEAL SWELLING 27
979 PULMONARY MASS 27
980 RHEUMATOID FACTOR INCREASED 27
981 SKIN HAEMORRHAGE 27
982 SLEEP DEFICIT 27
983 SLOW RESPONSE TO STIMULI 27
984 SNORING 27
985 SYSTOLIC DYSFUNCTION 27
986 TYPE 1 DIABETES MELLITUS 27
987 WEIGHT FLUCTUATION 27
988 ABORTION 26
989 ACTIVITIES OF DAILY LIVING IMPAIRED 26
990 ANOSMIA 26
991 BACTERIAL INFECTION 26
992 CARDIAC MURMUR 26
993 DIABETES INSIPIDUS 26
994 DRUG MONITORING PROCEDURE NOT PERFORMED 26
995 ENERGY INCREASED 26
996 ERUCTATION 26
997 EXCESSIVE EYE BLINKING 26
998 EXCESSIVE MASTURBATION 26
999 FEELING OF DESPAIR 26